The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Mead Johnson Board Increases Dividend by 13 Percent

Wednesday, February 27, 2013

Mead Johnson Board Increases Dividend by 13 Percent16:05 EST Wednesday, February 27, 2013 GLENVIEW, Ill. (Business Wire) -- Mead Johnson Nutrition Company (NYSE: MJN) announced today that its board of directors has declared a regular quarterly dividend of $0.34 per share for the quarter ending March 31, 2013, a 13.3 percent increase from the prior rate of $0.30 per share. The board expects the annualized dividend to be $1.36 per share. The dividend will be paid on April 1, 2013, to shareholders of record at close of business on March 13, 2013. About Mead JohnsonMead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide.The company's mission is to nourish the world's children for the best start in life.The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's “Enfa” family of brands, including Enfamil® infant formula, is the world's leading brand franchise in pediatric nutrition. For more information, visit meadjohnson.com.Forward-Looking StatementsCertain statements in this news release are forward looking as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are identified by words such as “expects,” “intends” and “believes,” involve certain risks, uncertainties and assumptions that may cause actual results to differ materially from expectations as of the date of this news release. These risks include, but are not limited to: (1) the ability to sustain brand strength, particularly the Enfa family of brands; (2) the effect on the company's reputation of real or perceived quality issues; (3) the adverse effect of commodity costs; (4) increased competition from branded, private label, store and economy-branded products; (5) the effect of an economic downturn on consumers' purchasing behavior and customers' ability to pay for product; (6) inventory reductions by customers; (7) the adverse effect of changes in foreign currency exchange rates; (8) the effect of changes in economic, political and social conditions in the markets where we operate; (9) legislative, regulatory or judicial action that may adversely affect the company's ability to advertise its products or maintain product margins; (10) the possibility of changes in the Women, Infant and Children (WIC) program, or participation in WIC; and (11) the ability to develop and market new, innovative products. For additional information on these and other factors, see the risk factors identified in the company's periodic reports, including the annual report on Form 10-K for 2012, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with, or furnished to, the Securities and Exchange Commission, available upon request or at meadjohnson.com. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Mead Johnson Nutrition CompanyInvestors:Kathy MacDonald, (847) 832-2182kathy.macdonald@mjn.comMedia:Christopher Perille, (847) 832-2178chris.perille@mjn.com